Lv01
0 积分 2024-12-26 加入
AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation
1小时前
已完结
Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers
1小时前
已完结
The Synthesis of Nano-Doxorubicin and its Anticancer Effect
7个月前
已完结
Retrospective Analysis of Radiofrequency Ablation in Patients with Small Solitary Hepatocellular Carcinoma: Survival Outcomes and Development of a Machine Learning Prognostic Model
7个月前
已完结
Complete Metabolic Response by 18F-FDG PET/CT to Atezolizumab Plus Bevacizumab in Patients With Advanced Hepatocellular Carcinoma
8个月前
已完结
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial
8个月前
已完结
Complete Metabolic Response by 18F-FDG PET/CT to Atezolizumab Plus Bevacizumab in Patients With Advanced Hepatocellular Carcinoma
8个月前
已关闭
Dynamic Adaptation of Tumor Immune Response With Nivolumab Demonstrated by 18F-FDG PET/CT
8个月前
已完结
Multimode Ultrasound Model for Predicting the Early Treatment Response of Anti-VEGF Agents Plus Anti-PD-1 Antibody in Patients with Unresectable Hepatocellular Carcinoma
8个月前
已完结
Multimodal Imaging Response after the Singular or Combination Treatments of Vascular Endothelial Growth Factor Inhibitor and Immune Checkpoint Inhibitor
8个月前
已完结
皖公网安备34019202002308
